Clinical trial · Observational
Application of Deep-learning and Ultrasound Elastography in Opportunistic Screening of Breast Cancer
A Multi-center Study of Deep Learning Diagnosis and Ultrasound Elastography in Opportunistic Screening of Breast Cancer
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
As the most common cancer expected to occur all over the world, breast cancer still faces with the unsatisfied diagnostic accuracy in US imaging. S-detect is a sophisticated CAD system for breast US imaging based on deep learning algorithms. E-breast is a software installed in US machines which automatically reveals tumor elastographic features. This multi-center study intends to further validate the diagnostic efficiency of S-detect and E-breast in opportunistic breast cancer screening populations in China. Our hypothesis is that S-detect and E-breast can increase the diagnostic accuracy and specificity as compared to routinely US examinations by doctors.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Benign or malignant lesions as determined by pathology
- timeFrame
- From 2019.1.1 to 2020.1.1
- description
- The pathological diagnosis of benign or malignant lesions from surgery samples
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Female over 18 years of age; * Had breast lesions detected by ultrasound. * No clinical symptoms such as nipple discharge, while breast lesions were not palpable. * Received breast surgery within one week of ultrasound examination. * Agreed to participant in this study and signed informed consent. Exclusion Criteria: * Patients who had received a biopsy of breast lesion before the ultrasound examination. * Patients who were pregnant or lactating. * Patients who were undergoing neoadjuvant treatment.
References
Publications (0)
Data not yet available